Astellas US LLC et al v. USV Private Limited
| Gilead Sciences, Inc., Astellas US LLC and Astellas Pharma US, Inc. |
| USV Private Limited |
| 1:2020cv00793 |
| June 11, 2020 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 7, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 NOTICE OF SERVICE of (1) USV Private Limited's Rule 26(a)(1) Initial Disclosures; and (2) USV Private Limited's Paragraph 3 Disclosures filed by USV Private Limited.(Dorsney, Kenneth) |
| Filing 10 NOTICE OF SERVICE of Initial Disclosures and Disclosures Pursuant to Paragraph 3 and 4a of the Delaware Default Standard for Discovery filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Filing 9 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by USV Private Limited. (Dorsney, Kenneth) |
| Filing 8 ANSWER to #1 Complaint, by USV Private Limited.(Dorsney, Kenneth) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 7 SUMMONS Returned Executed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc.. USV Private Limited served on 6/12/2020, answer due 7/6/2020. (Oakes, Robert) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc.. (nmg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US, Inc., Astellas US LLC filed by Astellas Pharma US, Inc., Astellas US LLC. (nmg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183; US RE 47,301 E; US 8,524,883. (nmg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/13/2020. Date of Expiration of Patent: 2/2/2027.Thirty Month Stay Deadline: 11/13/2022. (nmg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against USV Private Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-2988296.) - filed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Civil Cover Sheet)(nmg) |
| No Summons Issued. (nmg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
